Treatment
Treatment literacy materials that cover the basics of hepatitis C treatment, research on efficacy in different key populations, and global treatment uptake.
Materials in this section
Recently Pregnant Women With Hepatitis C Face Gaps in Treatment
Among people starting treatment for opioid use, recently pregnant women were the least likely to receive antiviral therapy for HCV. More
Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C
Simplified approaches to treatment are critical for HCV elimination and are particularly relevant for populations difficult to retain in care. More
More Effective and Affordable Treatment Strategies for Hepatitis C
Innovative study identifies more effective and affordable treatment strategies for hepatitis C. More
Telemedicine Addiction Treatment Is an Effective Way to Offer Treatment for Hepatitis C
A report supports telehealth for opioid use disorder as an avenue to reach people at high risk of hepatitis C and treat those infected. More
Health Economic Outcomes of a Minimal Monitoring Approach to Providing HCV Therapy
The ACTG A5360 trial demonstrated that HCV treatment without planned on-treatment monitoring is safe and effective. More
Integrated Hepatitis C Care in Syringe Service Programs Improves Outcomes for People Who Inject Drugs
Tailored models within syringe service programs can overcome barriers and improve HCV cure rates in underserved populations. More
HCV and HIV Coinfection: Decreasing Barriers to an HCV Cure With Use of a Simplified Treatment Algorithm
In 2023, the AASLD/IDSA treatment guidelines were updated to include the addition of the simplified algorithm in treatment-naive individuals with HIV/HCV coinfection. More
Hepatitis C Reinfection After DAA Therapy Linked to Substance Use, Comorbid HCC
In a large cohort of U.S. veterans, repeat viremia in adults with HCV who achieve SVR via DAA therapy may be more frequent among younger populations and those with a history of substance use or comorbid HCC. More
Understanding Barriers to Hepatitis C Antiviral Treatment in Low–Middle-Income Countries
Through a structured search of open access informational sources and an informal peer-reviewed literature review, HCV treatment barriers were identified, compiled, analysed and summarized as recommendations for LMICs. More
Subspecialty Physicians’ Perspectives on Barriers and Facilitators of Hepatitis C Treatment: A Qualitative Study
A study examined the perspectives of subspecialist physicians caring for substantial numbers of patients with HCV to better understand barriers and facilitators of HCV treatment. More
